Coronavirus and Beyond: Responding to Biological Threats

Coronavirus and Beyond: Responding to Biological Threats

The 2019 novel coronavirus (2019-nCoV) outbreak exemplifies ongoing biothreats to global security, as each new threat tests principles of preparation and response at national, regional, and clinical levels. Tom Inglesby, MD, director of the Center for Health Security at the Johns Hopkins Bloomberg School of Public Health, discusses biosecurity with Angel Desai, MD, JAMA Fishbein fellow.

Jaksot(227)

COVID-19 CDC Update – Early January 2022

COVID-19 CDC Update – Early January 2022

Former CDC Executive Secretariat of the Advisory Committee on Immunization Practices Amanda Cohn, MD, joins JAMA Associate Editor Preeti Malani, MD, for the latest on the need for vaccination and boos...

11 Tammi 202232min

COVID-19 Update: Omicron Variant

COVID-19 Update: Omicron Variant

Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a ...

6 Joulu 202138min

Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Results With Persistent Physical Symptoms

Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Results With Persistent Physical Symptoms

Interview with Cédric Lemogne, MD, PhD, and Joane Matta, PhD, authors of Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among Fr...

8 Marras 202127min

October 2021 Medical News Summary

October 2021 Medical News Summary

COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes; Moving COVID-19 Testing Out of the Clinic and Into the Home; The Lingua Franca of Addiction—Stigmatizing Words That Wound Related Content: ...

26 Loka 202120min

Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Pa...

7 Loka 202117min

A New Vision for Nursing Homes

A New Vision for Nursing Homes

The longstanding shortcomings of the US nursing home model became more visible during the COVID-19 crisis. Terry Fulmer, PhD, RN, a geriatric nurse practitioner and president of the John A. Hartford F...

6 Loka 202124min

COVID-19 in Canada—Experience and Response to Waves 2 and 3

COVID-19 in Canada—Experience and Response to Waves 2 and 3

Canadian law gives the country's individual provinces and territories primary responsibility for coronavirus containment and mitigation. JAMA Associate Editor Preeti Malani, MD, MSJ, from the Universi...

28 Syys 202123min

Delivery of Ophthalmic Telemedicine During the COVID-19 Pandemic

Delivery of Ophthalmic Telemedicine During the COVID-19 Pandemic

Interview with Grayson W. Armstrong, MD, MPH, author of Association of Patient Characteristics With Delivery of Ophthalmic Telemedicine During the COVID-19 Pandemic, and Fasika Ambachew Woreta, MD, MP...

23 Syys 202116min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-mita-tulisi-tietaa
rss-poliisin-mieli
utelias-mieli
rss-duodecim-lehti
rss-metsantuntijat-podcast
mielipaivakirja
filocast-filosofian-perusteet
rss-astetta-parempi-elama-podcast
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
university-of-eastern-finland
docemilia
menologeja-tutkimusmatka-vaihdevuosiin
rss-bios-podcast
rss-tiedetta-vai-tarinaa
rss-ylistys-elaimille
rss-lapsuuden-rakentajat-podcast
rss-sosiopodi
rss-miljonaarien-tasavalta